Zhonglin Hao

Associate Professor

Zhonglin Hao

Associate Professor

Academic Appointment(s)

Medical College of Georgia
Department of Medicine: Hematology and Oncology

Bio

Dr. Hao is a physician scientist. As an oncologist, he delivers state-of-the-art care to patients with lung cancer. He is also engaged in the cutting edge research in molecular targeting and immunotherapy.

  • (706) 721-8785
  • (706) 721-7376
  • CN 2132

Education

  • Ph.D., Biochem/Biophysics and Molecul University of Tokyo, 1998

  • MD, Medicine (MD) Inner Mongolia Medical College, 1986

Certifications

  • Hematology American Board of Internal Medicine, 2010

  • Medical Oncology American Board of Internal Medicine, 2010

  • Internal Medicine American Board of Internal Medicine, 2007

  • PHY GA Composite Medical Brd, 2009

Awards & Honors

  • Patient Family Centered Care Awards 2011

  • Berlex, Schering AG Fellow 1999

  • Sumitomo Life Insurance Scholar 1998

  • Hirose International Scholarship 1997

  • Ito Foundation for Educational Exchange Award 1994

Courses Taught Most Recent Academic Year

  • GMED 5077

    Ambulatory Adult Select
  • GMED 5000

    Basic Clkshp Med Pt 1
  • GMED 5100

    Basic Clkshp Med Pt 2
  • RHON 5000

    Hematology-Oncology
  • GMED 5012

    Hematology/Oncology Extn.
  • RMED 5000

    Medicine

Teaching Interests

Fellows, Residents and medical students

Scholarship

Selected Recent Publications

  • Sunitinib: the antiangiogenic effects and beyond., 2016
    Journal Article, Academic Journal
  • Clinical utility and patient considerations in the use of Volasertib for acute myeloid leukemia, 2015
  • Tumor Lysis Syndrome in Metastatic Colon Cancer Following Treatment with Regorafenib, 2015
    Journal Article, Academic Journal
  • Volasertib for AML: clinical use and patient consideration, 2015
    Journal Article, Academic Journal
  • Tumor Lysis Syndrome in Metastatic Colon Cancer Following Treatment with Regorafenib International , 2015

Research Interests

Small and Non-small cell lung cancer Molecularly targeted therapy, small molecule drugs Immune checkpoints and T-regulatory cells Cell cycle and checkpoint

University Service

  • PRMC 2012 - Present

    Role: Other